INNOVATE Corp (VATE)
NYSE:VATE
VATE Stock Chart & Stats
$5.05
$0.04(0.71%)
At close: 4:00 PM EST
$5.05
$0.04(0.71%)
Day’s Range― - ―
52-Week Range$3.75 - $8.52
Previous CloseN/A
Volume9.40K
Average Volume (3M)26.90K
Market Cap
$62.63M
Enterprise Value$531.98M
Total Cash (Recent Filing)$112.10M
Total Debt (Recent Filing)$717.50M
Price to Earnings (P/E)―
Beta1.95
Next Earnings
May 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding13,655,062
10 Day Avg. Volume53,214
30 Day Avg. Volume26,900
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)5.48
Price to Sales (P/S)0.05
P/FCF Ratio0.50
Enterprise Value/Market Cap8.49
Enterprise Value/Revenue0.43
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda8.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Cash GenerationA strong rebound to $146.6M operating cash flow and $120.5M free cash flow in 2025 materially improves the company's near-term liquidity and ability to fund operations, capex or targeted paydowns. Over the next 2–6 months this creates durable optionality to reduce refinancing risk and support strategic investments.
Large Backlog And Revenue MomentumA ~ $500M uplift in DBM Global's backlog to ~$1.6B provides multi‑period revenue visibility and work-in-hand for the Infrastructure segment. That backlog underpins predictable cash conversion and reduces near-term top-line volatility, supporting durable revenue and operational planning into 2026.
Regulatory And Clinical ValidationRegulatory approval and peer-reviewed recognition for MediBeacon's Lumitrace/TGFR technology establish clinical credibility and open large markets. This structural validation supports sustained commercialization, adoption in centers of excellence, and long-term revenue growth in the life‑sciences vertical.
Bears Say
Extremely High LeverageVery elevated indebtedness and minimal equity (debt-to-equity ~53x) materially constrain financial flexibility. Over the medium term this raises refinancing and covenant risk, increases sensitivity to interest rates, and limits capacity to invest organically or pursue M&A without additional capital or asset sales.
Persistent Losses And Negative EBITDAOngoing annual net losses and a negative 2025 EBITDA margin indicate the business is not yet consistently converting revenue into operating profits. Sustained unprofitability weakens retained earnings, limits internal capital formation and makes the firm more reliant on cash or external financing to cover operations.
Margin Compression And Segment RiskMaterial margin erosion at DBM and weakness in Spectrum signal structural pressure on profitability from input costs, pricing, or end‑market demand. Even with higher revenues and backlog, persistent margin compression can erode cash conversion and the durability of reported top-line gains across cycles.
INNOVATE Corp News
VATE FAQ
What was INNOVATE Corp’s price range in the past 12 months?
INNOVATE Corp lowest stock price was $3.75 and its highest was $8.52 in the past 12 months.
What is INNOVATE Corp’s market cap?
INNOVATE Corp’s market cap is $62.63M.
When is INNOVATE Corp’s upcoming earnings report date?
INNOVATE Corp’s upcoming earnings report date is May 12, 2026 which is in 45 days.
How were INNOVATE Corp’s earnings last quarter?
INNOVATE Corp released its earnings results on Mar 26, 2026. The company reported -$0.585 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.585.
Is INNOVATE Corp overvalued?
According to Wall Street analysts INNOVATE Corp’s price is currently Overvalued.
Does INNOVATE Corp pay dividends?
INNOVATE Corp pays a Notavailable dividend of $38.9 which represents an annual dividend yield of N/A. See more information on INNOVATE Corp dividends here
What is INNOVATE Corp’s EPS estimate?
INNOVATE Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INNOVATE Corp have?
INNOVATE Corp has 13,655,062 shares outstanding.
What happened to INNOVATE Corp’s price movement after its last earnings report?
INNOVATE Corp reported an EPS of -$0.585 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.896%.
Which hedge fund is a major shareholder of INNOVATE Corp?
Currently, no hedge funds are holding shares in VATE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
INNOVATE Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
VATE Sentiment 50%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 13.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.61%
12-Months-Change
Fundamentals
Return on Equity
33.49%
Trailing 12-Months
Asset Growth
1.78%
Trailing 12-Months
Company Description
INNOVATE Corp
INNOVATE Corp (VATE) is a forward-thinking technology company specializing in cutting-edge solutions across various sectors including artificial intelligence, renewable energy, and advanced manufacturing. The company focuses on developing innovative products and services that enhance efficiency and sustainability for businesses and consumers alike, leveraging its expertise in software development, hardware integration, and data analytics.
VATE Company Deck
VATE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic advancements in various segments, such as significant backlog increases and regulatory approvals. However, there were challenges such as margin compression, declines in Spectrum revenue, and increased indebtedness.View all VATE earnings summariesTechnical Analysis
SUNation Energy
―
Energy Services of America
―
Shimmick Corporation
―
SKK Holdings Limited
―
Ming Shing Group Holdings Limited
―
Ownership Overview
56.51% Insiders
3.14% Mutual Funds
8.38% Other Institutional Investors
30.21% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---